Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Radiant Innovation Inc. (3373:TWSE), powered by AI.
Radiant Innovation Inc. is currently trading at $16.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Radiant Innovation Inc. on Alpha Lenz.
View Radiant Innovation Inc.'s valuation metrics on Alpha Lenz.
“Radiant Innovation Inc.'s ROE is -7.3%. Explore profitability and growth together.”
Ask for details →Radiant Innovation Inc. is a technology-driven manufacturer specializing in the research, development, and production of infrared (IR) technology products, with a primary focus on medical equipment. Established in 2000 and headquartered in Hsinchu, Taiwan, the company is recognized for designing and manufacturing a broad range of medical infrared thermometers, including ear and forehead temperature measurement devices, as well as non-contact thermometers. In addition to its core offerings, Radiant Innovation Inc. produces carbon dioxide monitors, infrared thermal imagers, and electronic components such as blood glucose chipsets and specialized temperature sensors for industrial and healthcare applications. The company's products are distributed both domestically and internationally, serving markets across Asia, the Americas, and Europe. Radiant Innovation Inc.'s commitment to research and quality is underscored by its ISO 9001 and ISO 13485 certifications, as well as regulatory approvals from major bodies such as the EU, US FDA, and China CPA. Through continuous investment in innovation and a global ODM/OEM business model, the firm plays a significant role in the medical technology and electronic instrumentation sectors, supporting advancements in healthcare diagnostics and industrial monitoring.
“Radiant Innovation Inc.'s ROE is -7.3%. Explore profitability and growth together.”
Ask for details →Radiant Innovation Inc. (ticker: 3373) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 16.8 with a P/E ratio of -x and P/B of -x.
ROE is -7.28% and operating margin is -18.15%. Annual revenue is $388M.